These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36561992)

  • 1. Spatio-temporal delivery of both intra- and extracellular toll-like receptor agonists for enhancing antigen-specific immune responses.
    Wang N; Zuo Y; Wu S; Huang C; Zhang L; Zhu D
    Acta Pharm Sin B; 2022 Dec; 12(12):4486-4500. PubMed ID: 36561992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer Immunotherapy.
    Zhang L; Wu S; Qin Y; Fan F; Zhang Z; Huang C; Ji W; Lu L; Wang C; Sun H; Leng X; Kong D; Zhu D
    Nano Lett; 2019 Jul; 19(7):4237-4249. PubMed ID: 30868883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-delivery of antigen and dual agonists by programmed mannose-targeted cationic lipid-hybrid polymersomes for enhanced vaccination.
    Zhu D; Hu C; Fan F; Qin Y; Huang C; Zhang Z; Lu L; Wang H; Sun H; Leng X; Wang C; Kong D; Zhang L
    Biomaterials; 2019 Jun; 206():25-40. PubMed ID: 30925286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spleen-selective co-delivery of mRNA and TLR4 agonist-loaded LNPs for synergistic immunostimulation and Th1 immune responses.
    Pan L; Zhang L; Deng W; Lou J; Gao X; Lou X; Liu Y; Yao X; Sheng Y; Yan Y; Ni C; Wang M; Tian C; Wang F; Qin Z
    J Control Release; 2023 May; 357():133-148. PubMed ID: 36972863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-delivery of Dual Toll-Like Receptor Agonists and Antigen in Poly(Lactic-Co-Glycolic) Acid/Polyethylenimine Cationic Hybrid Nanoparticles Promote Efficient
    Ebrahimian M; Hashemi M; Maleki M; Hashemitabar G; Abnous K; Ramezani M; Haghparast A
    Front Immunol; 2017; 8():1077. PubMed ID: 28955328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monophosphoryl lipid A-assembled nanovaccines enhance tumor immunotherapy.
    Li R; Hao Y; Pan W; Wang W; Min Y
    Acta Biomater; 2023 Nov; 171():482-494. PubMed ID: 37708924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists.
    Baljon JJ; Kwiatkowski AJ; Pagendarm HM; Stone PT; Kumar A; Bharti V; Schulman JA; Becker KW; Roth EW; Christov PP; Joyce S; Wilson JT
    ACS Nano; 2024 Mar; 18(9):6845-6862. PubMed ID: 38386282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pickering emulsion-guided monomeric delivery of monophosphoryl lipid A for enhanced vaccination.
    Du Y; Lv J; Hao Z; Li Z; Song T; Ge H; Wang H; Yu Z; Xie Z; Li D; Liu Y
    J Control Release; 2024 Oct; 374():39-49. PubMed ID: 39111597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual TLR agonist nanodiscs as a strong adjuvant system for vaccines and immunotherapy.
    Kuai R; Sun X; Yuan W; Ochyl LJ; Xu Y; Hassani Najafabadi A; Scheetz L; Yu MZ; Balwani I; Schwendeman A; Moon JJ
    J Control Release; 2018 Jul; 282():131-139. PubMed ID: 29702142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanovaccine loaded with poly I:C and STAT3 siRNA robustly elicits anti-tumor immune responses through modulating tumor-associated dendritic cells in vivo.
    Luo Z; Wang C; Yi H; Li P; Pan H; Liu L; Cai L; Ma Y
    Biomaterials; 2015 Jan; 38():50-60. PubMed ID: 25457983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen epitope-TLR7/8a conjugate as self-assembled carrier-free nanovaccine for personalized immunotherapy.
    Song H; Su Q; Shi W; Huang P; Zhang C; Zhang C; Liu Q; Wang W
    Acta Biomater; 2022 Mar; 141():398-407. PubMed ID: 35007785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomimetic virus-like mesoporous silica nanoparticles improved cellular internalization for co-delivery of antigen and agonist to enhance Tumor immunotherapy.
    Gao Y; Zhang Y; Xia H; Ren Y; Zhang H; Huang S; Li M; Wang Y; Li H; Liu H
    Drug Deliv; 2023 Dec; 30(1):2183814. PubMed ID: 36843529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic Polymeric Mixed Micelles Targeting Lymph Nodes Trigger Enhanced Cellular and Humoral Immune Responses.
    Li C; Zhang X; Chen Q; Zhang J; Li W; Hu H; Zhao X; Qiao M; Chen D
    ACS Appl Mater Interfaces; 2018 Jan; 10(3):2874-2889. PubMed ID: 29285934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facile preparation of a metal-phenolic network-based lymph node targeting nanovaccine for antitumor immunotherapy.
    Su Q; Liu Z; Du R; Chen X; Chen L; Fu Z; Luo X; Yang Y; Shi X
    Acta Biomater; 2023 Mar; 158():510-524. PubMed ID: 36603733
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Yang J; Dong X; Li B; Chen T; Yu B; Wang X; Dou X; Peng B; Hu Q
    Front Bioeng Biotechnol; 2022; 10():1050077. PubMed ID: 36727039
    [No Abstract]   [Full Text] [Related]  

  • 16. "Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells.
    Elamanchili P; Lutsiak CM; Hamdy S; Diwan M; Samuel J
    J Immunother; 2007; 30(4):378-95. PubMed ID: 17457213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An allergen-fused dendritic cell-binding peptide enhances in vitro proliferation of equine T-cells and cytokine production.
    Ziegler A; Olzhausen J; Hamza E; Stojiljkovic A; Stoffel MH; Garbani M; Rhyner C; Marti E
    Vet Immunol Immunopathol; 2022 Jan; 243():110351. PubMed ID: 34800874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination of TLR7/8 Agonist-Conjugated Antigen Nanoparticles for Cancer Immunotherapy.
    Wang N; Zhang G; Zhang P; Zhao K; Tian Y; Cui J
    Adv Healthc Mater; 2023 Sep; 12(22):e2300249. PubMed ID: 37016572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of protective antigen of Bacillus anthracis as a model recombinant antigen to evaluate toll-like receptors 2, 3, 4, 7 and 9 agonists in mice using established functional antibody assays, antigen-specific antibody assays and cellular assays.
    Inglefield J; Catania J; Harris A; Hickey T; Ma Z; Minang J; Baranji K; Spangler T; Look J; Ruiz C; Lu H; Alleva D; Reece JJ; Lacy MJ
    Vaccine; 2022 Sep; 40(38):5544-5555. PubMed ID: 35773119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-adjuvant Astragalus polysaccharide-based nanovaccines for enhanced tumor immunotherapy: a novel delivery system candidate for tumor vaccines.
    Li N; Zhang Y; Han M; Liu T; Wu J; Xiong Y; Fan Y; Ye F; Jin B; Zhang Y; Sun G; Sun X; Dong Z
    Sci China Life Sci; 2024 Apr; 67(4):680-697. PubMed ID: 38206438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.